City of Philadelphia v. Chas. Pfizer & Co.

345 F. Supp. 454, 1972 Trade Cas. (CCH) 74,033, 1972 U.S. Dist. LEXIS 13500
CourtDistrict Court, S.D. New York
DecidedMay 31, 1972
Docket68 Civ. 4298, 68 Civ. 4299, 69 Civ. 4629
StatusPublished
Cited by28 cases

This text of 345 F. Supp. 454 (City of Philadelphia v. Chas. Pfizer & Co.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
City of Philadelphia v. Chas. Pfizer & Co., 345 F. Supp. 454, 1972 Trade Cas. (CCH) 74,033, 1972 U.S. Dist. LEXIS 13500 (S.D.N.Y. 1972).

Opinion

WYATT, District Judge.

This is a petition by Harold E. Kohn (and by other counsel associated with him), attorney for plaintiffs in these class actions, for an order approving a fee of $2,000,000, to be paid by defendants to Kohn and his associates. The petition is undated but was submitted in open Court on January 24, 1972 in the presence of counsel for defendants and was at that time ordered by me to be filed and docketed. Mr. Kohn and counsel for defendants were heard on that occasion. Decision on the petition was reserved.

Mr. Kohn is an experienced lawyer in antitrust matters; his office is in Philadelphia. He personally took the active part amongst the petitioners; he and his associate, Miss Korman (one of the petitioners) are known to me from their *455 appearances before me; the other petitioners are not known to me and I am not personally aware of any relevant activity by them.

A “Supplement to Petition”, also undated, was thereafter mailed to the Clerk and was received for filing on February 14, 1972.

The caption of the petition shows three civil actions in which Kohn represents the plaintiffs. Apparently, notice of the petition was given to defendants only. When the petition was heard, only defendants were represented and had been notified.

I. Commencement of the Actions Now Being Settled

A. Commencement of Actions Before Verdict in the Criminal Case

The extensive background of these three class actions and many similar actions need not be here reviewed in detail. It is described in my opinions in State of West Virginia v. Chas. Pfizer & Co., D.C., 314 F.Supp. 710, affirmed 2 Cir., 440 F.2d 1079 and in Hartford Hospital v. Chas. Pfizer & Co., D.C., 52 F.R.D. 131 (see on appeal from denial of motion to intervene, American Hospital Assn. v. Chas. Pfizer & Co., 2 Cir., 448 F.2d 790).

For present purposes, the history may begin with the filing on August 17, 1961 of an indictment in this District naming Pfizer, Cyanamid and Bristol as defendants (61 Cr. 772) along with some individuals, whose motions to dismiss were subsequently granted (United States v. Chas. Pfizer & Co., D.C., 245 F.Supp. 801). The indictment charged violation of the antitrust laws in respect of broad spectrum antibiotic drugs. It was some time before any civil claim was asserted against defendants. In time, however, many similar civil actions were commenced. All of these actions not commenced in this District were transferred here by the Judicial Panel on Multidistrict Litigation.

1.

In 1963, Premo Pharmaceutical Corporation (Premo), a drug business operating from New Jersey, began to import tetracycline from Italy. Pfizer on September 20, 1963 commenced an action for patent infringement against Premo in the United States District Court for the District of New Jersey (C.A. 766-63). Premo filed in that action a counterclaim asserting violation by Pfizer of the antitrust laws. Premo then retained a lawyer, Dennis, to assist patent counsel in prosecuting the counterclaim.

2.

In the following year, 1964, Premo was low bidder for sales of tetracycline to the City of New York but, since Pfizer had threatened the City with a patent infringement suit if it bought from Premo, the City in buying from Premo required Premo to post an indemnity bond. By this time, Dennis had become a partner in the law firm of Dickstein, Shapiro & Galligan. Premo consulted this firm in connection with the furnishing of the indemnity bond to the City.

In June 1964, Pfizer commenced an action in this Court against the City of New York and against the surety on Premo’s indemnity bond; the complaint alleged infringement of the Conover patent. This is an action still pending (64 Civ. 1742).

The defendant City of New York retained as its counsel Dickstein, Shapiro & Galligan; on July 1, 1964, these lawyers filed an answer. This answer contained a counterclaim asserting a cause of action for treble damages against Pfizer, Cyanamid, Bristol, Squibb and Upjohn for violation of the antitrust laws. The counterclaim was based on the charges in the indictment and in substantial part is word for word copied from the indictment. The counterclaim did not set out any claim for a class. Mr. Shapiro and Mr. Galligan have not only been active in the City of *456 New York action but, as will appear, have been active in many other actions involving antibiotic antitrust claims.

3.

It was some time before any claim similar to that of the City of New York was asserted against defendants. (On July 13, 1964, Premo commenced an action in this Court (64 Civ. 2163) against the defendants other than Pfizer.)

In November 1966, the Shapiro firm negotiated a settlement of the Premo litigation. A chief feature of the settlement was a license by Pfizer to Premo and two other companies to make, sell, etc. tetracycline. This license, according to Shapiro and as agreed implicitly by all other counsel for plaintiffs, marked the end of the claimed antitrust law violations.

4.

On August 4, 1967, the State of Texas commenced an action in the Northern District of Texas (CA 3-2165; after transfer here, 68 Civ. 4375). The Shapiro firm was of counsel. This was the first action commenced by a plaintiff to assert treble damage antitrust claims against defendants. It was a class action for the State of Texas and all cities, counties, and other political subdivisions in Texas which had bought antibiotics during the relevant period. (City, county, and state entities are, in the context of these actions, often called “CCS” entities and the actions are often called “CCS” actions.)

5.

In August 1967, Pfizer commenced a patent infringement action in the Central District of California (67-793-R; after transfer here, 68 Civ. 4541) against Benalen Corporation, a wholesale drug house. On August 24, 1967, Benalen filed an answer with a counterclaim for violation of the antitrust laws. The counterclaim as then filed did not state a claim for a class. On September 18, 1967, Benalen filed an amended counterclaim which did assert the antitrust claim for a class of all drug wholesalers in California who had bought and resold antibiotics at wholesale in the relevant period. This was the first civil antitrust claim asserted against defendants by a wholesale druggist. Counsel for Benalen have been Schwartz & Alschuler, for whom Benjamin F. Schwartz and Herbert A. Karzen have been principally engaged.

6.

On September 18, 1967, Domaro, a California retail druggist, commenced an action against defendants in the Central District of California (67-1366-R; after transfer here, 68 Civ. 4542). The Schwartz firm represented Domaro. The claim was stated for a class of all retail druggists in California who bought and resold antibiotics at retail in the relevant period. This was the first civil antitrust claim asserted against defendants by a retail drug store.

7.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Malchman v. Davis
761 F.2d 893 (Second Circuit, 1985)
Blatt v. Dean Witter Reynolds InterCapital, Inc.
732 F.2d 304 (Second Circuit, 1984)
Rybicki v. STATE BD. OF ELECTIONS OF ILLINOIS
574 F. Supp. 1161 (N.D. Illinois, 1983)
Folsom v. Butte County Assn. of Governments
652 P.2d 437 (California Supreme Court, 1982)
Fischer v. International Telephone & Telegraph Corp.
78 F.R.D. 237 (E.D. New York, 1978)
City of Detroit v. Grinnell Corp.
560 F.2d 1093 (Second Circuit, 1977)
City Of Detroit v. Grinnell Corporation
560 F.2d 1093 (Second Circuit, 1977)
Prandini v. National Tea Co.
557 F.2d 1015 (Third Circuit, 1977)
Dorey Corp. v. E. I. duPont De Nemours & Co.
426 F. Supp. 944 (S.D. New York, 1977)
Anthony v. Superior Court
59 Cal. App. 3d 760 (California Court of Appeal, 1976)
In Re Penn Central Securities Litigation
416 F. Supp. 907 (E.D. Pennsylvania, 1976)
Jamison v. Butcher & Sherrerd
68 F.R.D. 479 (E.D. Pennsylvania, 1975)

Cite This Page — Counsel Stack

Bluebook (online)
345 F. Supp. 454, 1972 Trade Cas. (CCH) 74,033, 1972 U.S. Dist. LEXIS 13500, Counsel Stack Legal Research, https://law.counselstack.com/opinion/city-of-philadelphia-v-chas-pfizer-co-nysd-1972.